Cell therapy for retinal disease

Goutham R Yalla1,2, Ajay E Kuriyan1

  • 1Wills Eye Hospital, Mid Atlantic Retina.

PubMed
Abstract

Insights

Stem cell therapy shows promise for retinal diseases like macular degeneration and retinitis pigmentosa, but larger trials are needed to confirm efficacy. Patient education and regulation are crucial due to fraudulent clinics.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Stem cell therapy is being investigated for various retinal diseases.
  • Clinical trials have assessed its safety and role in conditions like age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa.

Conclusions:

  • Current clinical trials are characterizing the safety of stem cell therapy in retinal disease.
  • Larger, powered studies are necessary to definitively evaluate the efficacy of stem cell therapy for preventing retinal disease progression.
  • Regulation and patient education are essential to mitigate complications arising from unapproved stem cell therapy providers.